Ingmar Bruns
Chief Medical Officer · Zentalis Pharmaceuticals, Inc.
- 2024
- Oct 1, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ingmar Bruns files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- WALTERS GROUP - $22.92M in ZNTL purchases and sales in the last 12 months
- Vincent Vultaggio - $105K in ZNTL purchases and sales in the last 12 months
- Julia Marie Eastland - $21K in ZNTL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ingmar Bruns?
Ingmar Bruns is a corporate insider, tracked as Chief Medical Officer of Zentalis Pharmaceuticals, Inc. (ZNTL). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ingmar Bruns submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Ingmar Bruns been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($8K) across all tracked filings.
